As of 2025-02-19, the Relative Valuation of SAGE Therapeutics Inc (SAGE) is (229.72) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.18 USD, the upside of SAGE Therapeutics Inc based on Relative Valuation is -3299.5%.
The range of the Relative Valuation is (193.95) - (264.72) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
Range | Selected | |
Trailing P/E multiples | 29.8x - 46.8x | 38.4x |
Forward P/E multiples | 26.2x - 40.6x | 32.1x |
Fair Price | (193.95) - (264.72) | (229.72) |
Upside | -2801.2% - -3786.9% | -3299.5% |
Date | P/E |
2025-02-18 | -1.10 |
2025-02-14 | -1.10 |
2025-02-13 | -1.10 |
2025-02-12 | -1.10 |
2025-02-11 | -1.10 |
2025-02-10 | -1.11 |
2025-02-07 | -1.11 |
2025-02-06 | -1.12 |
2025-02-05 | -1.11 |
2025-02-04 | -1.11 |
2025-02-03 | -1.11 |
2025-01-31 | -1.11 |
2025-01-30 | -1.13 |
2025-01-29 | -1.12 |
2025-01-28 | -1.13 |
2025-01-27 | -1.14 |
2025-01-24 | -1.09 |
2025-01-23 | -1.08 |
2025-01-22 | -1.08 |
2025-01-21 | -1.06 |
2025-01-17 | -1.09 |
2025-01-16 | -1.07 |
2025-01-15 | -1.11 |
2025-01-14 | -1.14 |
2025-01-13 | -1.15 |
2025-01-10 | -0.85 |
2025-01-08 | -0.90 |
2025-01-07 | -0.92 |
2025-01-06 | -0.95 |
2025-01-03 | -0.94 |
2025-01-02 | -0.89 |
2024-12-31 | -0.83 |
2024-12-30 | -0.83 |
2024-12-27 | -0.85 |
2024-12-26 | -0.88 |
2024-12-24 | -0.84 |
2024-12-23 | -0.83 |
2024-12-20 | -0.86 |
2024-12-19 | -0.77 |
2024-12-18 | -0.77 |
2024-12-17 | -0.81 |
2024-12-16 | -0.82 |
2024-12-13 | -0.83 |
2024-12-12 | -0.87 |
2024-12-11 | -0.90 |
2024-12-10 | -0.85 |
2024-12-09 | -0.85 |
2024-12-06 | -0.86 |
2024-12-05 | -0.86 |
2024-12-04 | -0.86 |